Correlation Between Evogene and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Evogene and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Champions Oncology, you can compare the effects of market volatilities on Evogene and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Champions Oncology.
Diversification Opportunities for Evogene and Champions Oncology
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Evogene and Champions is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Evogene i.e., Evogene and Champions Oncology go up and down completely randomly.
Pair Corralation between Evogene and Champions Oncology
Given the investment horizon of 90 days Evogene is expected to under-perform the Champions Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Evogene is 1.14 times less risky than Champions Oncology. The stock trades about -0.14 of its potential returns per unit of risk. The Champions Oncology is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 978.00 in Champions Oncology on November 18, 2024 and sell it today you would earn a total of 129.00 from holding Champions Oncology or generate 13.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Evogene vs. Champions Oncology
Performance |
| Timeline |
| Evogene |
| Champions Oncology |
Evogene and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evogene and Champions Oncology
The main advantage of trading using opposite Evogene and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Evogene vs. Arcus Biosciences | Evogene vs. Fate Therapeutics | Evogene vs. Pluri Inc | Evogene vs. Lexaria Bioscience Corp |
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |